NCT00263263View on ClinicalTrials.gov

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

December 31, 2005

Conditions
Stable AnginaUnstable AnginaCoronary Artery DiseaseSaphenous Vein Graft Disease
Interventions
DEVICE

sirolimus-eluting stent

DEVICE

bare metal stent

Trial Locations (1)

2020

Antwerp Cardiovascular Institute Middelheim, Antwerp

All Listed Sponsors
lead

Antwerp Cardiovascular Institute Middelheim

OTHER

NCT00263263 - RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent. | Biotech Hunter | Biotech Hunter